Central anticholinergic, neuroleptic malignant and serotonin syndromes: Important differential diagnoses in postoperative impairment of consciousness

T Hölle, JC Purrucker, B Morath, MA Weigand… - Die …, 2023 - europepmc.org
Bewusstseinsstörungen sind nach Allgemeinanästhesien ein häufiges Phänomen. Neben
den klassischen Ursachen (z. B. Überhang von sedierenden Medikamenten) kann eine …

[HTML][HTML] Neuroleptic malignant syndrome: the value of diagnostic criteria

TA Rowland, A Banga, N Ayadurai - The Primary Care Companion …, 2018 - psychiatrist.com
To the Editor: Neuroleptic malignant syndrome (NMS) is a rare but potentially serious
reaction to antipsychotic medications. The incidence of NMS is around 0.9%, 1 with an …

Outcomes of gastrointestinal cancer surgeries in Parkinson's disease patients: A nationwide study

S Kodama, T Jo, H Yasunaga, N Michihata… - Parkinsonism & Related …, 2022 - Elsevier
Background Parkinson's disease (PD) patients with comorbid cancers are increasing in
aging populations. However, little is known about the impact of PD on the outcomes of …

Syndrome malin des neuroleptiques

CM Tan, A Kumachev - CMAJ, 2024 - Can Med Assoc
Il se caractérise par de la rigidité, une altération de l'état mental, l'hyperthermie et la
dysfonction autonome (c.-à-d., diaphorèse, tachycardie, tachypnée et labilité de la tension …

[HTML][HTML] Neuroleptic Malignant Syndrome Concurrent with COVID-19 Infection: A Case Report

O Gökçen, M Akkuş - Turkish Journal of Psychiatry, 2024 - ncbi.nlm.nih.gov
Neuroleptic malignant syndrome (NMS), which most often occurs after the use of
antipsychotics, is a rare but life-threatening condition. In this article, a 56-year-old male …

Risperidone-associated neuroleptic malignant syndrome in an inpatient with Schizophrenia, with successful rechallenge and 3 year follow-up

TR Chen, YC Chen - Frontiers in Psychiatry, 2018 - frontiersin.org
Neuroleptic malignant syndrome (NMS) is rare but one of the most serious adverse effects of
antipsychotics. Here, we report a case of risperidone-associated NMS in which a successful …

[HTML][HTML] Síndrome neuroléptico maligno debido a ziprasidona: reporte de un caso

J Huarcaya-Victoria, C Castillo… - Revista de Neuro …, 2019 - scielo.org.pe
El síndrome neuroléptico maligno es una rara y potencialmente fatal reacción adversa
medicamentosa, asociada usualmente al uso de antipsicóticos. Tiene por características la …

Clinical utility of neutrophil–lymphocyte ratio in the diagnosis of neuroleptic malignant syndrome

N Karamustafalioglu, T Kalelioglu… - Nordic Journal of …, 2019 - Taylor & Francis
Background: Neuroleptic malignant syndrome (NMS) is a life-threatening side effect of
antipsychotic medication. In this study, we aimed to investigate the hypothesis of …

Nöroleptik Malign Sendrom nedir? Tanı ve tedavi yaklaşımları

M Baltacıoğlu, Ç Hocaoğlu - Journal of Contemporary Medicine, 2019 - dergipark.org.tr
Nöroleptik Malign Sendrom (NMS), santral dopaminerjik sistemi etkileyen ilaçların, en sık da
antipsikotiklerin kullanımı sonrası ortaya çıkan nadir görülen fakat hayatı tehdit eden …

[HTML][HTML] Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal

K Maeda, T Ichiba, K Kashiwa, Y Okazaki - Cureus, 2023 - ncbi.nlm.nih.gov
Neuroleptic malignant syndrome (NMS) is a potentially fatal side effect that occurs in
patients taking antipsychotics. Patients with NMS are often forced to rechallenge …